Murphy Canyon Acquisition Corp.
Status: Closed Deal
U=S+W
W=S@11.50
| IPO Proceeds, $M | $132.25M |
|---|---|
| IPO Date | Feb 3, 2022 |
| CEO | Jack K. Heilbron |
| Left Lead | A.G.P |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12 + 12 |
| IPO Sector | Real Estate ▶ |
| IPO Geography | Global |
| Target Company | Conduit Pharmaceuticals |
| Deal Announced | Nov 8, 2022 |
| Deal Size, $M | $716.55M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Sep 20, 2023 |
| Amendment Vote | Jan 26, 2023 |
| Closing Date | Sep 22, 2023 |
Formerly MURF
CDT
CDTWW
| Price | $2.87 $0.00 |
|---|---|
| Last closing price | $2.95 |
| H/L, today | $2.79 / $2.96 |
| H/L, 52-week | $0.95 / $12.89 |
| Volume, today | 33,800 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.